GALAPAGOS

Galapagos is a clinical-stage biotechnology company, specialized in the discovery and development of small molecule medicines with novel modes of action. Our ambition is to become a leading global biopharmaceutical company, focused on the discovery, development and commercialization of innovative medicines that will improve people's lives.

#SimilarOrganizations #People #Financial #Event #Website #More

GALAPAGOS

Social Links:

Twitter

Industry:

Biopharma Biotechnology Clinical Trials Health Care Medical

Founded:

1999-01-01

Address:

Mechelen-bovelingen, Limburg, Belgium

Country:

Belgium

Website Url:

http://www.glpg.com

Total Employee:

251+

Status:

Active

Contact:

+32 15 34 29 00

Email Addresses:

[email protected]

Total Funding:

5.45 B USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Content Delivery Network

Similar Organizations

affimed-logo

Affimed

Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.

Current Advisors List

onno-stolpe_image

Onno Stolpe Member of Board of Directors @ Galapagos
Board_member
1999-01-01

katrine-bosley_image

Katrine Bosley Board Member @ Galapagos
Board_member
2013-01-01

stephen-bunting_image

Stephen Bunting Board memeber @ Galapagos
Board_member

Current Employees Featured

onno-stolpe_image

Onno Stolpe
Onno Stolpe CEO @ Galapagos
CEO
1999-01-01

werner-cautreels_image

Werner Cautreels
Werner Cautreels Director @ Galapagos
Director

andre-hoekema_image

Andre Hoekema
Andre Hoekema Chief Business Officer @ Galapagos
Chief Business Officer

bart-filius_image

Bart Filius
Bart Filius Chief Operating Officer & Chief Financial Officer @ Galapagos
Chief Operating Officer & Chief Financial Officer

walid-abi-saab_image

Walid Abi-Saab
Walid Abi-Saab Chief Medical Officer @ Galapagos
Chief Medical Officer

piet-wigerinck_image

Piet Wigerinck
Piet Wigerinck Chief Scientific Officer @ Galapagos
Chief Scientific Officer

kruti-popat_image

Kruti Popat
Kruti Popat Director, Customer Insights & Engagement @ Galapagos
Director, Customer Insights & Engagement

paul-passier_image

Paul Passier
Paul Passier Director Clinical Pharmacology @ Galapagos
Director Clinical Pharmacology
2018-01-01

michele-manto_image

Michele Manto
Michele Manto Chief Commercial Officer @ Galapagos
Chief Commercial Officer
2020-01-01

philip-vyt_image

Philip Vyt
Philip Vyt Senior Director Global Omnichannel Capabilities & Digital Innovation @ Galapagos
Senior Director Global Omnichannel Capabilities & Digital Innovation
2020-10-01

Founder

dinko-valerio_image

Dinko Valerio

onno-stolpe_image

Onno Stolpe

rudi-pauwels_image

Rudi Pauwels

Stock Details

Company's stock symbol is VIE:GLPG

Acquisitions List

Date	Company	Article	Price
2022-06-21	CellPoint	CellPoint acquired by Galapagos	125 M EUR
2021-06-21	Abound Bio	Abound Bio acquired by Galapagos	14 M USD
2013-01-15	Cangenix	Cangenix acquired by Galapagos	N/A
2010-02-02	Argenta Discovery	Argenta Discovery acquired by Galapagos	N/A
2007-01-02	ProStrakan	ProStrakan acquired by Galapagos	31 M EUR
2006-12-07	Inpharmatica	Inpharmatica acquired by Galapagos	19.1 M EUR
2005-09-21	BioFocus DPI	BioFocus DPI acquired by Galapagos	36.5 M USD

Investors List

gilead-sciences_image

Investments List

Date	Company	Article	Money raised
2013-07-01	Vitalnext	Galapagos investment in Funding Round - Vitalnext	N/A

Key Employee Changes

Date	New article
2022-01-26	Galapagos appoints Paul Stoffels as Chief Executive Officer

Official Site Inspections

http://www.glpg.com Semrush global rank: 39.37 K Semrush visits lastest month: 3.28 M

Host Informations
Whois Informations

Loading ...